O. Martínez‐García

发表

Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone

J. Vázquez-Barquero, R. Tabarés-Seisdedos, B. Crespo-Facorro, 2013, Psychopharmacology.

Treatment of first-episode non-affective psychosis: a randomized comparison of aripiprazole, quetiapine and ziprasidone over 1 year

B. Crespo-Facorro, R. Perez-Iglesias, I. Mata, 2013, Psychopharmacology.

Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.

J. Vázquez-Barquero, B. Crespo-Facorro, R. Perez-Iglesias, 2009, The Journal of clinical psychiatry.

Treatment of first-episode non-affective psychosis: a randomized comparison of aripiprazole, quetiapine and ziprasidone over 1 year

B. Crespo-Facorro, R. Perez-Iglesias, I. Mata, 2013, Psychopharmacology.

A digit symbol coding task as a screening instrument for cognitive impairment in first-episode psychosis.

J. Vázquez-Barquero, B. Crespo-Facorro, R. Perez-Iglesias, 2011, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population

J. Vázquez-Barquero, B. Crespo-Facorro, R. Perez-Iglesias, 2009, Schizophrenia Research.

Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: A 3 months randomized study

J. Leza, B. Crespo-Facorro, M. López-Hoyos, 2018, Schizophrenia Research.

Differential associations of cognitive insight components with pretreatment characteristics in first-episode psychosis

B. Crespo-Facorro, R. Ayesa-Arriola, M. Alvarez-Jimenez, 2014, Psychiatry Research.

First-episode schizophrenia patients neuropsychologically within the normal limits: Evidence of deterioration in speed of processing

Benedicto Crespo-Facorro, José Luis Vázquez-Barquero, José Manuel Rodríguez-Sánchez, 2010, Schizophrenia Research.

Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study.

J. Vázquez-Barquero, R. Tabarés-Seisdedos, B. Crespo-Facorro, 2012, Journal of psychiatric research.

Long-term (3-year) effectiveness of haloperidol, risperidone and olanzapine: results of a randomized, flexible-dose, open-label comparison in first-episode nonaffective psychosis

J. Vázquez-Barquero, B. Crespo-Facorro, R. Perez-Iglesias, 2011, Psychopharmacology.

Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine.

J. Vázquez-Barquero, B. Crespo-Facorro, R. Perez-Iglesias, 2011, Journal of psychiatric research.

Effectiveness of haloperidol, risperidone and olanzapine in the treatment of first-episode non-affective psychosis: results of a randomized, flexible-dose, open-label 1-year follow-up comparison

J. Vázquez-Barquero, B. Crespo-Facorro, R. Perez-Iglesias, 2011, Journal of psychopharmacology.

Homocysteine and cognition in first-episode psychosis patients

J. Vázquez-Barquero, R. Tabarés-Seisdedos, B. Crespo-Facorro, 2012, European Archives of Psychiatry and Clinical Neuroscience.

Prognostic value of cognitive functioning for global functional recovery in first-episode schizophrenia

B. Crespo-Facorro, R. Perez-Iglesias, J. M. Rodríguez-Sánchez, 2009, Psychological Medicine.

Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.

J. Vázquez-Barquero, B. Crespo-Facorro, R. Perez-Iglesias, 2007, Journal of psychiatric research.

Insight dimensions in first‐episode psychosis patients: clinical, cognitive, pre‐morbid and socio‐demographic correlates

J. Vázquez-Barquero, B. Crespo-Facorro, R. Perez-Iglesias, 2011, Early intervention in psychiatry.

A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.

J. Vázquez-Barquero, B. Crespo-Facorro, R. Perez-Iglesias, 2007, The Journal of clinical psychiatry.

Effects of Family Psychoeducation on Expressed Emotion and Burden of Care in First-Episode Psychosis: A Prospective Observational Study

J. Vázquez-Barquero, B. Crespo-Facorro, M. Alvarez-Jimenez, 2010, The Spanish journal of psychology.

Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial.

J. Vázquez-Barquero, B. Crespo-Facorro, R. Perez-Iglesias, 2006, The Journal of clinical psychiatry.

Long-term effect of haloperidol, olanzapine, and risperidone on plasma prolactin levels in patients with first-episode psychosis.

J. Vázquez-Barquero, B. Crespo-Facorro, R. Perez-Iglesias, 2012, Journal of clinical psychopharmacology.

Possible effects of some antipsychotic drugs on C-reactive protein in a drug-naïve psychotic sample

J. Vázquez-Barquero, B. Crespo-Facorro, R. Perez-Iglesias, 2010, Schizophrenia Research.

A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.

Benedicto Crespo-Facorro, Javier Llorca, B. Crespo-Facorro, 2006, The Journal of clinical psychiatry.

Lack of association between clinical and cognitive change in first-episode psychosis: the first 6 weeks of treatment.

J. Vázquez-Barquero, B. Crespo-Facorro, R. Perez-Iglesias, 2008, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors.

R. Tabarés-Seisdedos, B. Crespo-Facorro, R. Perez-Iglesias, 2014, The international journal of neuropsychopharmacology.

The effect of excess weight on circulating inflammatory cytokines in drug-naïve first-episode psychosis individuals

J. Leza, B. Crespo-Facorro, M. López-Hoyos, 2018, Journal of Neuroinflammation.

Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: Findings of a randomized clinical trial in a drug-naïve population

J. Vázquez-Barquero, B. Crespo-Facorro, R. Perez-Iglesias, 2008, Schizophrenia Research.

Course of cognitive deficits in first episode of non-affective psychosis: A 3-year follow-up study

R. Tabarés-Seisdedos, B. Crespo-Facorro, R. Perez-Iglesias, 2013, Schizophrenia Research.

Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP)

R. Tabarés-Seisdedos, B. Crespo-Facorro, R. Ayesa-Arriola, 2017, European Archives of Psychiatry and Clinical Neuroscience.

Stopping cannabis use benefits outcome in psychosis: findings from 10‐year follow‐up study in the PAFIP‐cohort

B. Crespo-Facorro, R. Ayesa-Arriola, K. Neergaard, 2019, Acta psychiatrica Scandinavica.

Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up

B. Crespo-Facorro, R. Ayesa-Arriola, A. Ferro, 2018, Schizophrenia Research.

Epidemiological factors associated with treated incidence of first‐episode non‐affective psychosis in Cantabria: insights from the Clinical Programme on Early Phases of Psychosis

J. Vázquez-Barquero, D. Tordesillas-Gutiérrez, B. Crespo-Facorro, 2008, Early intervention in psychiatry.

Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis

B. Crespo-Facorro, R. Perez-Iglesias, I. Mata, 2007, Psychological Medicine.

The effect of excess weight on circulating inflammatory cytokines in drug-naïve first-episode psychosis individuals

J. Leza, B. Crespo-Facorro, M. López-Hoyos, 2018, Journal of Neuroinflammation.

Dissecting the functional outcomes of first episode schizophrenia spectrum disorders: a 10-year follow-up study in the PAFIP cohort

D. Tordesillas-Gutiérrez, B. Crespo-Facorro, R. Ayesa-Arriola, 2019, Psychological Medicine.

Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment

R. Tabarés-Seisdedos, B. Crespo-Facorro, K. Neergaard, 2017, Psychopharmacology.

Long-term (3-year) effectiveness of haloperidol, risperidone and olanzapine: results of a randomized, flexible-dose, open-label comparison in first-episode nonaffective psychosis

J. Vázquez-Barquero, B. Crespo-Facorro, R. Perez-Iglesias, 2011, Psychopharmacology.

Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial

J. Vázquez-Barquero, B. Crespo-Facorro, R. Perez-Iglesias, 2010, Schizophrenia Research.

Using structural equations to test for a direct effect of some antipsychotics on triglyceride levels in drug-naïve first-episode psychosis patients

J. Vázquez-Barquero, B. Crespo-Facorro, R. Perez-Iglesias, 2011, Schizophrenia Research.

Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study

B. Crespo-Facorro, J. Crespo, E. Fábrega, 2016, Psychopharmacology.

Aripiprazole, Ziprasidone, and Quetiapine in the Treatment of First-Episode Nonaffective Psychosis: Results of a 6-Week, Randomized, Flexible-Dose, Open-Label Comparison

J. Vázquez-Barquero, B. Crespo-Facorro, R. Perez-Iglesias, 2013, Journal of clinical psychopharmacology.

Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.

B. Crespo-Facorro, E. Valdizán, O. Martínez-García, 2016, The Journal of clinical psychiatry.

Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone

J. Vázquez-Barquero, R. Tabarés-Seisdedos, B. Crespo-Facorro, 2013, Psychopharmacology.

Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial

J. Vázquez-Barquero, B. Crespo-Facorro, R. Perez-Iglesias, 2010, Schizophrenia Research.

Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment

R. Tabarés-Seisdedos, B. Crespo-Facorro, K. Neergaard, 2017, Psychopharmacology.

Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study.

J. Vázquez-Barquero, R. Tabarés-Seisdedos, B. Crespo-Facorro, 2012, Journal of psychiatric research.

Using structural equations to test for a direct effect of some antipsychotics on triglyceride levels in drug-naïve first-episode psychosis patients

J. Vázquez-Barquero, B. Crespo-Facorro, R. Perez-Iglesias, 2011, Schizophrenia Research.